SVRA•benzinga•May 19, 2025 at 06:54 AM

Reported Sunday, Savara Presents Phase 3 IMPALA-2 Data At ATS 2025 Showing Molgramostim Reduces Surfactant Burden And Improves Quality Of Life In aPAP Patients

No summary available.

Read the full article from the original source for complete details and context.

Article published on May 19, 2025 by benzinga